US District Court for the District of Delaware Intellectual Property Cases
Cases 21 - 30 of 1,214
Novartis Pharmaceuticals Corporation et al v. MSN Pharmaceuticals Inc. et al
as 1:2024cv01193
Defendant:
MSN Pharmaceuticals Inc. and MSN Laboratories Pvt. Ltd.
Plaintiff:
Novartis Pharmaceuticals Corporation and Astex Therapeutics Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Sandoz Inc. v. Boehringer Ingelheim Pharmaceuticals Inc. et al
as 1:2024cv01192
Defendant:
Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals Inc.
Plaintiff:
Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Allergan Holdings Unlimited Company et al v. Sun Pharmaceutical Industries Limited
as 1:2024cv01188
Plaintiff:
Eden Biodesign, LLC, AbbVie Inc., Allergan Holdings Unlimited Company and others
Defendant:
Sun Pharmaceutical Industries Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ViiV Healthcare Company, et al v. Hetero USA Inc. et al
as 1:2024cv01189
Plaintiff:
ViiV Healthcare UK (No. 3) Limited, ViiV Healthcare Company and Shionogi & Co., Ltd.
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-III and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Allergan Holdings Unlimited Company et al v. MSN Laboratories Private Limited et al
as 1:2024cv01187
Defendant:
MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited
Plaintiff:
AbbVie Inc., Eden Biodesign, LLC, AbbVie US LLC and others
Counter-Claimant:
MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited
Counter-Defendant:
AbbVie Inc., Eden Biodesign, LLC, AbbVie US LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Actelion Pharmaceuticals US, Inc. et al v. Lannett Company, Inc.
as 1:2024cv01162
Plaintiff:
Shinyaku Co., Ltd., Actelion Pharmaceuticals US, Inc. and Actelion Pharmaceuticals Ltd
Defendant:
Lannett Company, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Advanced Accelerator Applications USA, Inc. et al v. Curium US LLC et al
as 1:2024cv01161
Defendant:
Curium US Holdings LLC, Curium US LLC, Curium International Trading BV and others
Plaintiff:
Advanced Accelerator Applications SA and Advanced Accelerator Applications USA, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Pfizer Inc. et al v. Breckenridge Pharmaceutical, Inc.
as 1:2024cv01122
Plaintiff:
PF PRISM IMB B.V., C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC and others
Defendant:
Breckenridge Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Galderma Laboratories, L.P. et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2024cv01105
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
TCD Royalty Sub LP and Galderma Laboratories, L.P.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Granules India Limited
as 1:2024cv01091
Plaintiff:
Boehringer Ingleheim International GMBH, Boehringer Ingleheim Pharma GMBH & Co. KG and Boehringer Ingleheim Pharmaceuticals Inc.
Defendant:
Granules India Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
